Compare Mondaycom Ltd (MNDY) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mondaycom Ltd vs Sanofi SA — how do they compare? Mondaycom Ltd trades at $81.4 (market cap $3.43B), while Sanofi SA trades at $42.96 (market cap $103.41B). The key difference: Sanofi SA is far larger — about 30.1× Mondaycom Ltd's market cap, and Sanofi SA pays a 5.65% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.
| MNDY | SNY | |
|---|---|---|
Market Cap | $3.43B | $103.41B |
Sector | Technology | Health |
52-Week High | $219.15 | $52.34 |
52-Week Low | $58.81 | $41.33 |
Enterprise Value | $2.59B | $123.44B |
Dividend Yield | — | 5.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MNDY trades at $83.67, down 8.13% over 24 hours, with a bearish technical signal but strong fundamentals including 88.74% gross margins and consecutive earnings beats. Revenue grew to $1.23B in 2025, though net cash flow turned negative in 2026. Recent news highlights inclusion in growth stock lists and AI-driven monetization gains.
Outlook is mixed: analyst consensus is bullish with a $106 price target, but technical weakness and negative cash flow trends pose risks. The stock offers growth potential from operational efficiency and market positioning, yet investors face volatility from competitive pressures and execution challenges.
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
